No Detail Found!

Post Partum Hemorrhage Prevention with Tranexamic Acid is effective and Safe in Comparison to Placebo.

Author(s)
Mamuna Qayum Rangers Hospital Lahore Pakistan
Waleed Ali Rangers Hospital Lahore Pakistan
Nomira Waheed Rangers Hospital Lahore Pakistan
Abstract
Objective: To compare the tranexamic acid effectiveness and safety with placebo for prevention of post partum hemorrhage (PPH) on general population of Lahore. Study Design: Randomized double blind placebo control trial. Place and Duration of Study: This study was conducted over a period of two years and six month (Jan 2015 to Jun 2017) in Ranger Hospital and Cavalry Hospital Lahore. Material and Methods: A total 600 cases were randomly selected from obstetric outpatient departments of both hospitals for delivery. Patients were divided in two groups, 300 patients received tranexamic acid and 300 patients received placebo. In tranxamic acid group, in cases of vaginal deliveries a loading dose of 01 gram tranexamic acid was injected intravenously at delivery of anterior shoulder. In cases of lower segment caesarean section it was administered intravenously prior to abdominal incision. Those patients who failed to response, a second dose of 01 gram tranxamic acid were repeated at 30 minutes - 01 hour interval. In similar manner placebo was injected in second group. Results: In tranexamic acid group, 289 (96%) patients responded successfully. Second dose was needed in 8 patients. Out of these 8 cases, 4 patients responded successfully. Those 4 women who failed to respond to tranxamic acid, 2 patients had venous thrombosis, 1 case was of placenta increate and 1 case was of uterine atony. Life saving total abdominal hysterectomy was performed in case of placenta increate. The patient of uterine atony required surgical intervention. In this study tranexamic acid administration was associated with reduction in blood loss after vaginal delivery 88.2 ± 15.5 mlversus 300 ± 35 ml in placebo group, and was significantly effective (p<0.001). In case of caesarean sections, blood loss was reduced 153.2 ± 21 ml in tranexamic acid group versus 745 ± 72.5 ml in placebo. The reduction was significant (p<0.001). Minor gastrointestinal side effects were common after tranexamic acid use. Thromboembolic events were same in both groups. Conclusion: Tranexamic acid effectively reduced post-partum blood loss along utro-tonics. Tranexamic acid is a safe drug which can reduce the primary PPH along with utrotonics.
Publication Details
Page(s) 908-913
DOI DOI not available
Published Journal: Pakistan Armed Forces Medical Journal, Volume: 68, Issue: 4, Year: 2018

Request the full text from PASTIC

References
2012.1. WHO recommendations for the prevention and treatment of postpartum haemorrhage, -
AtukundaEC,MugyenyiGR,ObuaC,AtuhumuzaEB,MusinguziN., 2016.Measuring post partum haemorrhage in lowresource settings: The diagnostic validity of weighed blood loss versus quantitative change in hemoglobin,Plos one 11 e0152408 -
NishidaT,KinoshitaT,YamakawaK., 2017.Tranexamic acid and trauma-induced coagulopathy,J Intensive Care 5 1186 -
KnightM,NairM,TuffnellD,KenyonS,ShakespeareJ,BrocklehurstP, 2017.Surveillance of maternal deaths in the UK 2012-14 and lessons learned to inform maternity care from the UK and Ireland Confidential Enquiries into Maternal Deaths,Morbidity 19 1 -95
VictoraCG,RequejoJH,BarrosAJD,BermanP,BhuttaZ,BoermaT, 2016.A decade of tracking progress for maternal, newborn, and child survival,Lancet 387 2049 -59
KerrRS,WeeksAD, 2015.Lessons from 150 years of UK maternal hemorrhage deaths,Acta Obstet Gynecol Scand 94 664 -8
ShahN., 2014.Post-partum hemorrhage: 60% of maternal deaths preventable with a Rs17 drug, stress experts Tribune Pakistan Karachi Sindh,The Express Tribune -
AlkemaL,ChouD,HoganD,ZhangS,GemmillA,FatDM, 2016.Global, regional and national levels and trends in maternal mortality between 1990 and 2015 with scenario - based projections to 2030: A systemic analysis by the UN Maternal Mortality Estimation Inter,Lancet 387 462 -74
SentilhesL,LasockiS,Ducloy-BouthorsAS,DeruelleP,DreyfusM,PerrotinF, 2015.Tranexamic acidfor the prevention and treatment of postpartum haemorrhage,Br J Anaesth 114 576 -87
KouidesPA,MaryM., 2017.Gppley hemophilia center inc. rochester, NY; and University of rochester school of medicine, rochester, NY. Antifirinolytic therapy for preventing VWD-related postpartum hrmorrhage: Indications and limitations,Blood advances 1 699 -702
ShiH,OuY,JiangD,QuanZ,ZhaoZ,ZhuY., e5718.Tranexamic acid reduces perioperative blood loss of posterior limber surgery for stenosis or spondylolisthesis: A randomized trial,Medicine 96 -
PabingerI,FriesD,TollerW., 2017.Tranexamic acid for treatment and prophylaxis of bleeding and hyperfibrinolysis,Wien Klin Wochenschr 129 303 -16
LiC,GongY,DongLL,XieB, 2017.Is prophylactic tranexamic acid administration effective and safe for Post Partum Hemorrhage prevention? A systemic review and meta-analysis,Medicine 96 e5653 -
GungorduK,AsiciagluO,YildirimG,ArkC, 2013.Can intravenous injection of Tranexamic acid be used in routine practice with active management of third stage of labour in vaginal delivery. A randomized controlled study,Am J Perinatal 30 407 -13
DerrickC.,Glymph , Tito D.,Tubog, 2016.Use of Tranexamic Acid in Preventing Postpartum Hemorrhage,AANA Journal 84 396 -403
HibbsSP,RobertsI,Shakur-StillH,HuntBJ, 2018.Post-partum haemorrhage and tranexamic acid: A global issue,Br J Haematol 180 799 -807
2017.Effect of early tranexamic acid administration on mortality, hysterectomy, and other morbidities in women with post-partum haemorrhage (woman): An international, randomised, double-blind, placebo-controlled trial,Lancet 389 2105 -16
MainE,ButwickA,DruzinML,GilbertW,GorlanJ,GuptaN, 2017.,Tranexamic acid forObstetrics Hemorrhage. CMQCC -
0

Citations

0

Downloads

86

Views